Š Koudelka, J Turánek - Journal of Controlled Release, 2012 - Elsevier
Over the past three decades, taxanes represent one of the most important new classes of
drugs approved in oncology. Paclitaxel (PTX), the prototype of this class, is an anti-cancer …